Cargando…

Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy

Acute kidney injury is very common in critically ill patients requiring renal replacement therapy. Despite the advancement in medicine, the mortality rate from septic shock can be as high as 60%. This manuscript describes drug-dosing considerations and challenges for clinicians. For instance, drugs’...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Soo Min, Infante, Sergio, Abdi Pour, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151686/
https://www.ncbi.nlm.nih.gov/pubmed/32046092
http://dx.doi.org/10.3390/pharmacy8010018
_version_ 1783521306977763328
author Jang, Soo Min
Infante, Sergio
Abdi Pour, Amir
author_facet Jang, Soo Min
Infante, Sergio
Abdi Pour, Amir
author_sort Jang, Soo Min
collection PubMed
description Acute kidney injury is very common in critically ill patients requiring renal replacement therapy. Despite the advancement in medicine, the mortality rate from septic shock can be as high as 60%. This manuscript describes drug-dosing considerations and challenges for clinicians. For instance, drugs’ pharmacokinetic changes (e.g., decreased protein binding and increased volume of distribution) and drug property changes in critical illness affecting solute or drug clearance during renal replacement therapy. Moreover, different types of renal replacement therapy (intermittent hemodialysis, prolonged intermittent renal replacement therapy or sustained low-efficiency dialysis, and continuous renal replacement therapy) are discussed to describe how to optimize the drug administration strategies. With updated literature, pharmacodynamic targets and empirical dosing recommendations for commonly used antibiotics in critically ill patients receiving continuous renal replacement therapy are outlined. It is vital to utilize local epidemiology and resistance patterns to select appropriate antibiotics to optimize clinical outcomes. Therapeutic drug monitoring should be used, when possible. This review should be used as a guide to develop a patient-specific antibiotic therapy plan.
format Online
Article
Text
id pubmed-7151686
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-71516862020-04-20 Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy Jang, Soo Min Infante, Sergio Abdi Pour, Amir Pharmacy (Basel) Opinion Acute kidney injury is very common in critically ill patients requiring renal replacement therapy. Despite the advancement in medicine, the mortality rate from septic shock can be as high as 60%. This manuscript describes drug-dosing considerations and challenges for clinicians. For instance, drugs’ pharmacokinetic changes (e.g., decreased protein binding and increased volume of distribution) and drug property changes in critical illness affecting solute or drug clearance during renal replacement therapy. Moreover, different types of renal replacement therapy (intermittent hemodialysis, prolonged intermittent renal replacement therapy or sustained low-efficiency dialysis, and continuous renal replacement therapy) are discussed to describe how to optimize the drug administration strategies. With updated literature, pharmacodynamic targets and empirical dosing recommendations for commonly used antibiotics in critically ill patients receiving continuous renal replacement therapy are outlined. It is vital to utilize local epidemiology and resistance patterns to select appropriate antibiotics to optimize clinical outcomes. Therapeutic drug monitoring should be used, when possible. This review should be used as a guide to develop a patient-specific antibiotic therapy plan. MDPI 2020-02-07 /pmc/articles/PMC7151686/ /pubmed/32046092 http://dx.doi.org/10.3390/pharmacy8010018 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Opinion
Jang, Soo Min
Infante, Sergio
Abdi Pour, Amir
Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
title Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
title_full Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
title_fullStr Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
title_full_unstemmed Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
title_short Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
title_sort drug dosing considerations in critically ill patients receiving continuous renal replacement therapy
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151686/
https://www.ncbi.nlm.nih.gov/pubmed/32046092
http://dx.doi.org/10.3390/pharmacy8010018
work_keys_str_mv AT jangsoomin drugdosingconsiderationsincriticallyillpatientsreceivingcontinuousrenalreplacementtherapy
AT infantesergio drugdosingconsiderationsincriticallyillpatientsreceivingcontinuousrenalreplacementtherapy
AT abdipouramir drugdosingconsiderationsincriticallyillpatientsreceivingcontinuousrenalreplacementtherapy